Atlas Trials

Pilot Study Combining Temozolomide, Oncovin, Camptosar and Oral Antibiotic in Children and Adolescents With Recurrent Malignancy

Clinical trial NCT00222443 · COMPLETED

Trial details

NCT number
NCT00222443
Sponsor
University of Oklahoma
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
LymphomasTumors
Start date
2004-09-01
Primary completion
2007-12-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.